Literature DB >> 25739488

[Use of nanoparticles (NP) in photodynamic therapy (PDT) against cancer].

Gabriela Victoria Roblero-Bartolón1, Eva Ramón-Gallegos1.   

Abstract

Nanotechnology is a promising interdisciplinary field for developing improved methods of diagnosis and treatment of different diseases, including cancer. Give their optical, magnetic, and structural property, the nanoparticles have been proposed to be use in the development of unconventional treatments for cancer such as photodynamic therapy (PDT). In PDT, a photosensitizing agent is used that accumulates in tumor cells, generating reactive oxygen species that causes the death of malignant cells after irradiation with light at a particular wavelength. However, the use of PDT presents different problems in its application due to the characteristics of hydrophobicity of the photosensitizers, which hinder the efficiency of administration and treatment. It is here where the use of nanoparticles is proposed as a delivery vehicle to optimize treatment application. In this review we describe the use of nanoparticles coupled to PDT in the treatment of cancer and its molecular mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25739488

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  3 in total

1.  Curcumin-Mediated Photodynamic Inactivation of Norovirus Surrogates.

Authors:  W Randazzo; R Aznar; G Sánchez
Journal:  Food Environ Virol       Date:  2016-08-05       Impact factor: 2.778

Review 2.  The application of titanium dioxide, zinc oxide, fullerene, and graphene nanoparticles in photodynamic therapy.

Authors:  Zahraa Youssef; Régis Vanderesse; Ludovic Colombeau; Francis Baros; Thibault Roques-Carmes; Céline Frochot; Habibah Wahab; Joumana Toufaily; Tayssir Hamieh; Samir Acherar; Amirah Mohd Gazzali
Journal:  Cancer Nanotechnol       Date:  2017-10-19

3.  New Targeted Gold Nanorods for the Treatment of Glioblastoma by Photodynamic Therapy.

Authors:  Zahraa Youssef; Nurlykyz Yesmurzayeva; Ludivine Larue; Valérie Jouan-Hureaux; Ludovic Colombeau; Philippe Arnoux; Samir Acherar; Régis Vanderesse; Céline Frochot
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.